Publications
- Léčba pokročilého a metastazujícího nemalobuněčného karcinomu plic bez řídicích mutací2023 | First Faculty of Medicine
- Treatment of ALK positive non-small cell lung cancer2021 | First Faculty of Medicine
- What approach to ALK-positive NSCLC?2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Clinical dilemma of lung cancer treatment with anti-PD-1 therapy (nivolumab) in the discovery of rheumatological problems with joint swelling - case report2020 | First Faculty of Medicine
- Lorlatinib in the treatment of non-small cell lung cancer2020 | First Faculty of Medicine
- Atezolizumab in the treatment of non-small cell lung cancer patients with EGFR and ALK mutation or rearrangement2019 | First Faculty of Medicine
- Léčba checkpoint inhibitory anti-PD-1 u starších pacientů2019 | First Faculty of Medicine
- Effects of Treatment with Crizotinib on Non-small Cell Lung Carcinoma with ALK Translocation in the Czech Republic2018 | First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Diagnosing lung cancer in pulmonology centers2018 | First Faculty of Medicine, Second Faculty of Medicine
- Nintedanib2016 | First Faculty of Medicine
Loading network view...